INS and type 2 diabetes mellitus: The challenge of tailoring insulin therapy to manage glucose excursions in T2D can be overcome with the use of glucose responsive insulin delivery, commonly referred to as ‘closed-loop’ or ‘artificial pancreas’ systems.